Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.
Safety of medical therapy in patients with chronic kidney disease and end-stage renal disease.
复制标题
慢性肾病和终末期肾病患者药物治疗的安全性。
DOI：
10.1097/01.mnh.0000444912.40418.45
复制
发表时间：
2014
影响因子：
3.2
通讯作者：
Fink,JeffreyC
中科院分区：
文献类型：
--
作者：
Weir,MatthewR;Fink,JeffreyC
有必要制定策略，提供住院和门诊管理计划，以限制在广泛的教育和社会经济背景下发生不良药物错误的风险，并且迫切需要制定一套统一的标准来评估CKD和ESRD患者的安全性，以及对CKD、肾移植或透析患者的典型安全性的适当描述。
There is an important need to develop strategies to provide inpatient and outpatient management plans to limit the risk of adverse medication errors across a wide range of educational and socioeconomic backgrounds, and a critical need to develop a uniform set of standards for evaluating patient safety in CKD and ESRD as well as appropriate descriptions of the prototypical safety profiles of patients who have CKD, a kidney transplant, or who are on dialysis.